慢病患者多重用药风险感知特点及影响因 素  

Characteristics and Influencing Factors of Risk Perception of Polypharmacy Behaviors inPatients with Chronic Diseases

作　　者：刘雨鑫 王佳 闫子麒 王若溪[2] 唐玉清[2] 冯达 LIU Yuxin;WANG Jia;YAN Ziqi;WANG Ruoxi;TANG Yuqing;FENG Da(School of Pharmacy,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;School of Medicine and Health Management,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]华中科技大学同济医学院药学院,武汉430030 [2]华中科技大学同济医学院医药卫生管理学院,武汉430030

出　　处：《医药导报》2021年第7期959-963,共5页Herald of Medicine

基　　金：国家自然科学基金青年科学基金资助项目(71804052)。

摘　　要：目的了解慢病患者在多重用药行为中的风险感知情况,探索慢病患者多重用药风险感知的影响因素,为规范慢病患者用药行为提供政策参考与建议。方法通过研究文献及咨询专家开发慢病患者多重用药风险感知量表。采取整群抽样方式,选取武汉市2家养老院及6家三甲医院开展现场调研,并采用SPSS23.0版统计软件对数据进行分析。结果武汉市慢病患者对多重用药风险感知程度整体偏低,但有部分患者表现出较高水平的经济风险感知。年龄、服药数量、抑郁状况会对老年慢病患者风险感知产生较大影响,其中年龄为主要影响因素,年龄越大的慢病患者,多重用药风险感知程度越低;同时服药数量少、抑郁程度轻的患者也表现出较低水平的多重用药风险感知。结论老年慢病患者对多重用药相关风险表现出较低的感知程度,相关部门可考虑制定针对老年慢病患者的政策以规范该群体患者合理用药。Objective To study the risk perception of chronic diseases patients in polypharmacy,to explore the influencing factors of patients'risk perception of polypharmacy,and to provide reference and recommendations for the formulation of policies regulating the drug use behavior of patients with chronic diseases.Methods The risk perception scale of polypharmacy for patients with chronic diseases was developed by literature research and expert consultation methods.The stratified random sampling method was adopted to select hospitals,nursing homes,township health centers in Wuhan.And data collection was conducted through on-site investigation.The data was analyzed by SPSS 23.0 software.Results Most chronic diseases patients have low risk perception of polypharmacy;However,there are some patients show a very high level of risk perception in the economy.The study also find that a variety of factors have an impact on the risk perception of chronic disease patients.Overall,age,number of medications taken,and depression status have a greater impact on risk perception of patients.Among them,age is the main influencing factor.The older patient with chronic diseases had the lower the risk perception of polypharmacy.Conclusion Elderly patients with chronic disease show lower levels of risk perception of polypharmacy,relevant authorities may consider formulating relevant policies for elderly chronic diseases patients to regulate the rational drug use behavior of these patients.

关 键 词：多重用药 慢病患者 老年 风险感知 

分 类 号：R95[医药卫生—药学] R969